Roche Holding AG - Net Income Including Non Controlling Interests
Roche Holding AG's Fiscal Year is From January To December - All Figures are in CHF, Billions.
The item "Net-Income-Including-Non-Controlling-Interests" stands at 5.50 Billion Swiss Francs for the trailing twelve months (TTM) period ending 06/30/2025, the lowest value at least since 12/31/2011, the period currently displayed.'
Regarding the One-Year-Change of the series, the current value constitutes a decrease of -52.33 percent compared to the value the year prior.
The 1 year change in percent is -52.33.
The 3 year change in percent is -65.41.
The 5 year change in percent is -66.22.
The 10 year change in percent is -60.12.
The Serie's change in percent from it's minimum value, on 06/30/2025, to it's latest available value, on 06/30/2025, is +0.0%.
The Serie's change in percent from it's maximum value, on 12/31/2019, to it's latest available value, on 06/30/2025, is -72.84%.
Net Income Including Non Controlling Interests for Related Companies:
| Logo | Name | Market Cap (USD) |
|---|---|---|
 | Eli Lilly and Company - Net Income Including Non Controlling Interests | 905,699,262,464.00 |
 | Johnson & Johnson - Net Income Including Non Controlling Interests | 486,508,953,600.00 |
 | AbbVie Inc - Net Income Including Non Controlling Interests | 399,570,305,024.00 |
 | AstraZeneca PLC - Net Income Including Non Controlling Interests | 280,205,508,085.11 |
 | Novartis AG - Net Income Including Non Controlling Interests | 255,096,620,580.91 |